Unilife Corporation (NASDAQ:UNIS) shares moved up 1.00% in last trading session and ended the day at $1.01. UNIS has a return on assets of -94.10%. Unilife Corporation (NASDAQ:UNIS) quarterly performance is 8.60%.
On 9 February, Unilife Corporation (NASDAQ:UNIS) announced its financial results for the second quarter of fiscal 2016 (three months ended December 31, 2015). Revenue for the second quarter of fiscal 2016 was $4.5 million, compared to $5.4 million in the same period last year. Cash receipts from customers for the second quarter of fiscal 2016 were $17.8 million, compared to $7.3 million in the same period last year.
Jabil Circuit Inc. (NYSE:JBL) ended the last trading day at $20.52. Company weekly volatility is calculated as 3.64% and price to cash ratio as 3.46. Jabil Circuit Inc. (NYSE:JBL) showed a weekly performance of 5.77%.
Jabil Circuit Inc. (NYSE:JBL) will all trade ex-dividend for their respective upcoming dividends. KLA-Tencor Corp. will pay its quarterly dividend of $0.52 on 3/1/16, Intersil Corp. will pay its quarterly dividend of $0.12 on 2/26/16, and Jabil Circuit, Inc. will pay its quarterly dividend of $0.08 on 3/1/16.
On 18 February, MRC Global Inc. (NYSE:MRC) shares moved down -1.67% and was closed at $9.41. MRC EPS growth in last 5 year was 21.50%. MRC Global Inc. (NYSE:MRC) year to date (YTD) performance is -27.05%.
MRC Global Inc. (NYSE:MRC) announced that its board of directors named Rhys J. Best as non-executive chairman effective as of its upcoming annual meeting of shareholders on April 28, 2016.
NVIDIA Corporation (NASDAQ:NVDA) shares advanced 8.60% in last trading session and ended the day at $30.04. NVDA Gross Margin is 56.00% and its has a return on assets of 8.40%. NVIDIA Corporation (NASDAQ:NVDA) quarterly performance is -0.81%.
On 14 February, NVIDIA Corporation (NASDAQ:NVDA) are now in the testing and validation phase. The Pascal GPU architecture is certainly one of Nvidia’s most-awaited products in 2016 and the latest news adds more to the excitement caused by its impending release.
FibroGen, Inc. (NASDAQ:FGEN) caters to the Healthcare space. It has a net profit margin of -49.30% and weekly performance is 28.05%. On the last day of trading company shares ended up at $19.31. FibroGen, Inc. (NASDAQ:FGEN) distance from 50-day simple moving average (SMA50) is -3.79%.
FibroGen, Inc. (NASDAQ:FGEN) announced that the American Journal of Kidney Disease has published Phase 2 data showing roxadustat, an investigational oral agent for the treatment of anemia in patients with chronic kidney disease (CKD), maintained hemoglobin levels among patients on hemodialysis previously treated with and switched from epoetin alfa ─ regardless of baseline iron repletion status, degree of inflammation (measured by C-reactive protein (CRP) level), or prior iron regimen ─ over two time periods of six and 19 weeks.